The downregulation of KLF2 expression is significantly correlated with the TNM staging of ccRCC, and ccRCC patients with low expression of KLF2 have significantly shorter overall survival and metastasis-free survival periods. The gene discussed is KLF2; the disease is nonpapillary renal cell carcinoma.